Global distribution of respiratory syncytial virus A and B infections: a systematic review
Review
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Respiratory syncytial virus (RSV) is the main cause of severe respiratory infections in young children. The need for global epidemiologic data regarding RSV has been increasingly recognized. RSV A infections are reported more frequently than RSV B. Nonetheless, the temporal distribution of infections caused by both RSV groups has not been investigated globally. A systematic review was carried out regarding published studies on RSV A and B epidemiology, as well as RSV G gene ectodomain sequence data available at GenBank. A total of 76,668 [45,990 (60%25) RSV A and 30,678 (40%25) RSV B] positive samples from 83 countries were identified and included in the analysis. Genotype assignment was obtained in 5,340 RSV A and 2,518 RSV B sequences. Two patterns of RSV circulation were observed: continuous seasons with RSV A predominance and alternate predominance of RSV A and B. These patterns were observed in all regions, but the predominant RSV group seldom coincided in all continents during a given year or season. The most frequently identified RSV A genotype was NA1 (including ON1 viruses) (76.30%25), and the most frequently identified RSV B genotype was BA (70.65%25). Multiple genotypes circulated simultaneously throughout the evolutionary history of RSV, but genotype diversity decreased after the year 2000. The classification of RSV group and genotype is important for the development of vaccines, as well as to understand viral dynamics. This study displays the global and continental RSV circulation patterns from the first report of human RSV infection until the end of 2020. © 2022 Informa UK Limited, trading as Taylor %26 Francis Group.
publication date
funding provided via
published in
Research
keywords
-
epidemiology; genotype; molecular epidemiology; Respiratory syncytial virus; respiratory viruses ectodomain; unclassified drug; vaccine; GenBank; gene frequency; gene sequence; genotype; genotyping; human; Human respiratory syncytial virus; Human respiratory syncytial virus A; incidence; molecular epidemiology; phylogenetic tree; phylogeny; respiratory syncytial virus infection; respiratory virus; Review; season; synthesis; systematic review; child; genetics; Human respiratory syncytial virus; infant; preschool child; respiratory syncytial virus infection; respiratory tract infection; Child; Child, Preschool; Genotype; Humans; Infant; Phylogeny; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Respiratory Tract Infections
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue